Literature DB >> 29784695

A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.

Matthew C Riddle1, Hertzel C Gerstein2, Rury R Holman3, Silvio E Inzucchi4, Bernard Zinman5, Sophia Zoungas6, William T Cefalu7.   

Abstract

Year:  2018        PMID： 29784695     DOI： 10.2337/dci18-0018

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  13 in total

1.  Large discrepancy in glycaemic control appropriateness in geriatric patients with type 2 diabetes according to major clinical practice guidelines.

Authors:  Antoine Christiaens; Séverine Henrard; Benoit Boland
Journal:  Eur Geriatr Med       Date:  2021-11-25       Impact factor: 1.710

Review 2.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

3.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

4.  Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.

Authors:  Susan L Karam; Jared Dendy; Shruti Polu; Lawrence Blonde
Journal:  Diabetes Spectr       Date:  2020-02

Review 5.  The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes.

Authors:  Gwang Sil Kim; Joong Hyun Park; Jong Chul Won
Journal:  Endocrinol Metab (Seoul)       Date:  2019-05-09

Review 6.  Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.

Authors:  Guido Gembillo; Ylenia Ingrasciotta; Salvatore Crisafulli; Nicoletta Luxi; Rossella Siligato; Domenico Santoro; Gianluca Trifirò
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

7.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetes Care       Date:  2018-10-04       Impact factor: 19.112

8.  Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study.

Authors:  Pierre Gourdy; Amar Bahloul; Zahra Boultif; Didier Gouet; Bruno Guerci
Journal:  Diabetes Ther       Date:  2019-11-28       Impact factor: 2.945

9.  Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment.

Authors:  John M Dennis
Journal:  Diabetes       Date:  2020-08-25       Impact factor: 9.461

10.  Immunonutritional Bioactives from Chenopodium quinoa and Salvia hispanica L. Flour Positively Modulate Insulin Resistance and Preserve Alterations in Peripheral Myeloid Population.

Authors:  Raquel Selma-Gracia; Polona Megušar; Claudia Monika Haros; José Moisés Laparra Llopis
Journal:  Nutrients       Date:  2021-05-02       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.